On Monday, Shares of Genetic Technologies Limited (ADR) (NASDAQ:GENE), gained 5.10% to $3.71.
Genetic Technologies Limited, declared, that underpinned by a strong balance sheet, following the successful capital raise in March 2015, the Company has launched an initiative to reinvigorate the pathway to Peer Review Publication. Attaining such publications in medical journals will assist to strengthen the Company’s commercial position and accelerate reimbursement discussions with private payers. In addition, the Company plans to conduct three U.S. clinical studies and is presently in the process of preparing for the presentation of recently accomplished scientific validation studies.
The Company had formerly conducted multiple scientific studies to develop and validate the first generation BREVAGen test in addition to created two health economic models to demonstrate potential cost savings and health benefits associated with the BREVAGen test. Importantly, due to the nature of the technology and the specific improvements incorporated in BREVAGenplus, the research undertaken and published based on the original version of the test remains applicable to the new iteration.
Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of genetic tests for breast and ovarian cancer, bowel and uterine cancer, and prostate cancer; neurogenetic diagnostic assays; and gene testing for Epilepsy SCN1A gene related disorders.
Shares of FormFactor, Inc. (NASDAQ:FORM), declined -6.54% to $6.86, during its last trading session.
FormFactor, will report financial results for its 2015 fiscal second quarter on Wednesday, July 29, 2015, at 1:30 p.m. Pacific Daylight Time. The public is invited to listen to a live webcast of FormFactor’s conference call on the Investors section of the company’s web site at www.formfactor.com. A telephone replay of the conference call will be accessible about two hours after the conclusion of the call. The telephone replay will be accessible through July 31, 2015, 9:00 p.m. Pacific Daylight Time, and can be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international) and entering confirmation code 78964868.
FormFactor, Inc. designs, develops, manufactures, sells, and supports semiconductor probe card products and solutions worldwide. The company’s probe cards are used to perform wafer test, which is the testing of the semiconductor die or chips on the semiconductor wafer.
Finally, Scripps Networks Interactive, Inc. (NYSE:SNI), ended its last trade with -0.88% loss, and closed at $64.29.
Scripps Networks Interactive, will report second quarter 2015 operating results before the market opens Tuesday, Aug. 4. A telephone conference call with members of the company’s senior administration team will follow at 10 a.m. ET.
Scripps Networks Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
